Clinical Trial Update: Topical Nitroglycerin To Prevent Radial Artery Occlusion After Transradial Access: NTP-RAO Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating topical nitroglycerin to prevent radial artery occlusion after transradial access (NTP-RAO Trial).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radial Artery Occlusion
• Total Atherosclerotic Occlusion of Radial Artery

Drugs mentioned

• Nitroglycerin (topical) (nitroglycerin)

Snippet

Sponsor: Total Cardiovascular Solutions | Conditions: Total Atherosclerotic Occlusion of Radial Artery | Phase 3 | Status: UNKNOWN